Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Real-time PCR technology for cancer diagnostics.

Philip S Bernard1, Carl T Wittwer

  • 1Department of Pathology, University of Utah School of Medicine, 30 North 1900 East, Salt Lake City 84132, USA. phil.bernard@path.utah.edu

Clinical Chemistry
|July 27, 2002
PubMed
Summary

Molecular profiling of solid tumors using DNA-based PCR techniques offers a promising approach for cancer diagnosis and treatment. Real-time PCR provides robust, cost-effective methods for tumor profiling in clinical settings.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The MHCII Immune Activation Score predicts risk of recurrence and benefit of taxanes in Basal-like and HER2-enriched breast cancer.

medRxiv : the preprint server for health sciences·2026
Same author

Real-Time Reverse Transcription Quantitative PCR (RT-qPCR) Methodological Standards and Reporting Practices.

Clinical chemistry·2026
Same author

Determination of Drug Sensitivity in Patient Derived Models of Breast Cancer by Multiparametric QPI.

bioRxiv : the preprint server for biology·2025
Same author

Fragile methods, fractured trust: rethinking scientific responsibility.

Methods (San Diego, Calif.)·2025
Same author

MIQE 2.0: Revision of the Minimum Information for Publication of Quantitative Real-Time PCR Experiments Guidelines.

Clinical chemistry·2025
Same author

Making Molecular Diagnostics Faster.

International journal of laboratory hematology·2025

Area of Science:

  • Oncology
  • Molecular Biology
  • Clinical Pathology

Background:

  • Current cancer staging relies on anatomic and histopathologic features.
  • Molecular diversity in cancers reveals new taxonomic, prognostic, and therapeutic possibilities.
  • Integrating molecular classifications into routine pathology practice is a key challenge.

Purpose of the Study:

  • To discuss the benefits, challenges, and potential of solid-tumor profiling in clinical laboratories.
  • To highlight the utility of DNA-based Polymerase Chain Reaction (PCR) techniques for molecular analysis.
  • To emphasize the need for translating molecular discoveries into clinical practice.

Main Methods:

  • Focus on DNA-based Polymerase Chain Reaction (PCR) techniques for solid-tumor profiling.

Related Experiment Videos

  • Discussion of quantitative real-time PCR for detecting gene duplications/deletions.
  • Exploration of melting curve analysis for identifying small DNA mutations.

    • Main Results:

    • Molecular markers aid in accurate prognosis and prediction of therapy response, resistance, or toxicity.
    • Real-time PCR methods are efficient for analyzing gene copy number variations and mutations.
    • These DNA-based techniques are becoming faster, easier, and amenable to multiplexing.

    Conclusions:

    • Translating oncology research discoveries into clinical practice requires objective, robust, and cost-effective molecular techniques.
    • Real-time PCR presents attractive features for routine tumor profiling in clinical laboratories.
    • DNA and protein markers are more stable and readily handled in clinical settings compared to RNA.